SMTI · Sanara MedTech Inc.
$34.15
+0.29 (+0.86%)
At close · Aug 3
Market Cap
$310.29M
Shares
9.16M
Sanara MedTech Inc. Earnings Call Transcripts
Every quarterly earnings call for Sanara MedTech Inc. (SMTI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼30.8%
$7.81M
−$3.13M
'22 Q1
22-05-16
▲54.1%
$9.67M
$769,426
'22 Q2
22-08-15
▲124%
$13.04M
−$1.47M
'22 Q3
22-11-14
▲1925.2%
$15.32M
−$4.11M
'22 Q4
23-03-20
▲98.7%
$15.52M
−$1.18M
'23 Q1
23-05-15
▲62.9%
$15.75M
−$1.83M
'23 Q2
23-08-14
▲22.8%
$16.02M
−$1.06M
'23 Q3
23-11-13
▲15.5%
$17.69M
−$237,194
'23 Q4
24-03-25
▲19.4%
$18.54M
−$1.76M
'24 Q1
24-05-13
▲28%
$20.16M
−$3.50M
'24 Q2
24-08-12
▲35.2%
$21.67M
−$2.86M
'24 Q3
24-11-12
▲26.4%
$23.43M
−$3.53M
'25 Q1
25-05-14
▲28.1%
$25.83M
−$2.01M
'25 Q2
25-08-13
▲21.5%
$26.33M
−$30.41M
'25 Q3
25-11-12
▲4.6%
$27.52M
−$1.61M
'25 Q4
26-01-23
LATEST
▲18.6%
$27.80M
$458,957
'26 Q1
26-05-11
Conference
Investor event
2026-11-05
AAHKS Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-10-06
Premier-Supplier Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-23
OTA Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-16
AOFAS Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-11
Sanara MedTech Inc. Q1 FY2026 Earnings Call
Confident tone
Sales team expansion and distribution
R&D pipeline and innovation
Revenue growth and product performance
Revenue
$27.80M
▲ 18.6% YoY Diluted EPS
$0.05
Gross margin
93.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-23
Sanara MedTech Inc. Q4 FY2025 Earnings Call
Confident tone
Net revenue growth and milestones
Vizient GPO contract and BIASURGE
OsStic launch and R&D investment
Revenue
$27.52M*
▲ 4.6% YoY Gross margin
93.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Sanara MedTech Inc. Q3 FY2025 Earnings Call
Positive tone
Core Surgical business growth
Tissue Health Plus (THP) wind-down
Leadership transition
Revenue
$26.33M
▲ 21.5% YoY Diluted EPS
$-3.40
Gross margin
92.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Sanara MedTech Inc. Q2 FY2025 Earnings Call
Confident tone
CarePICS acquisition and THP pilot
Surgical segment revenue growth
OsStic product launch
Revenue
$25.83M
▲ 28.1% YoY Diluted EPS
$-0.23
Gross margin
92.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Sanara MedTech Inc. Q1 FY2025 Earnings Call
Confident tone
Sanara Surgical revenue growth
Tissue Health Plus pilot launch
Facility and surgeon penetration
Revenue
$23.43M
▲ 26.4% YoY Diluted EPS
$-0.41
Gross margin
92.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-12
Sanara MedTech Inc. Q3 FY2024 Earnings Call
Confident tone
Tissue Health Plus (THP) Launch
ChemoMouthpiece / InfuSystem Partnership
Adjusted EBITDA and Path to Profitability
Revenue
$21.67M
▲ 35.2% YoY Diluted EPS
$-0.34
Gross margin
90.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Sanara MedTech Inc. Q2 FY2024 Earnings Call
Confident tone
Tissue Health Plus (THP) Launch
Surgical Segment Performance
Operational Infrastructure and New COO
Revenue
$20.16M
▲ 28% YoY Diluted EPS
$-0.41
Gross margin
90.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Sanara MedTech Inc. Q1 FY2024 Earnings Call
Confident tone
CEO transition and leadership changes
Tissue Health Plus value-based care strategy
SG&A and operating expenses rising with revenue
Revenue
$18.54M
▲ 19.4% YoY Diluted EPS
$-0.21
Gross margin
89.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-25
Sanara MedTech Inc. Q4 FY2023 Earnings Call
Confident tone
Product Launches and Pipeline
Tissue Health Plus / Value-Based Care Strategy
Revenue Growth
Revenue
$17.69M*
▲ 15.5% YoY Gross margin
89.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Sanara MedTech Inc. Q3 FY2023 Earnings Call
Revenue
$16.02M
▲ 22.8% YoY Diluted EPS
$-0.13
Gross margin
89.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Sanara MedTech Inc. Q2 FY2023 Earnings Call
Revenue
$15.75M
▲ 62.9% YoY Diluted EPS
$-0.22
▼ 344.4% YoY Gross margin
86.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Sanara MedTech Inc. Q1 FY2023 Earnings Call
Revenue
$15.52M
▲ 98.7% YoY Diluted EPS
$-0.14
Gross margin
86.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
Sanara MedTech Inc. Q4 FY2022 Earnings Call
Revenue
$15.32M*
▲ 1925.2% YoY Gross margin
84.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Sanara MedTech Inc. Q3 FY2022 Earnings Call
Revenue
$13.04M
▲ 124% YoY Diluted EPS
$-0.18
Gross margin
82.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Sanara MedTech Inc. Q2 FY2022 Earnings Call
Revenue
$9.67M
▲ 54.1% YoY Diluted EPS
$0.09
Gross margin
90.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Sanara MedTech Inc. Q1 FY2022 Earnings Call
Revenue
$7.81M
▼ 30.8% YoY Gross margin
89.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-15
Sanara MedTech Inc. Q3 FY2021 Earnings Call
Revenue
$5.82M
▲ 35.2% YoY Gross margin
91.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Sanara MedTech Inc. Q2 FY2021 Earnings Call
Revenue
$6.28M
▲ 111.6% YoY Gross margin
91.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts
CIK
714256
CUSIP
79957L100
13F (30d)
14 filings
14 filers
Visit website
Investor relations